The French Competition Authority fines a pharmaceutical laboratory for abuse of dominance by refusing to sell its medical information database (Euris / Cegedim)

Press Release published on the official website of the French Competition Authority.

The Autorité de la concurrence has imposed Cegedim a 5.7 million euros fine for having abusively refused to sell its medical information database to certain pharmaceutical laboratories* The medical databases market To optimise the work of their sales forces, pharmaceutical laboratories use two tools, namely, databases containing medical information, mainly for collecting the names and address details of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

French Competition Authority, The French Competition Authority fines a pharmaceutical laboratory for abuse of dominance by refusing to sell its medical information database (Euris / Cegedim), 8 July 2014, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 67801

Visites 297

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues